MedPath

Potassium citrate

Generic Name
Potassium citrate
Brand Names
Cytra-K, Urocit-K
Drug Type
Small Molecule
Chemical Formula
C6H5K3O7
CAS Number
866-84-2
Unique Ingredient Identifier
86R1NVR0HW

Overview

Potassium citrate (also known as tripotassium citrate) is a potassium salt of citric acid. It is a white, hygroscopic crystalline powder. It is odorless with a saline taste. It contains 38.3% potassium by mass. In the monohydrate form it is highly hygroscopic and deliquescent. Potassium citrate is used to treat a kidney stone condition called renal tubular acidosis. Potassium Citrate is indicated also for the management of Hypocitraturic calcium oxalate nephrolithiasis.

Indication

For the management of renal tubular acidosis, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis with or without calcium stones.

Associated Conditions

  • Bowel preparation therapy
  • Constipation
  • Hypocitraturic calcium oxalate nephrolithiasis
  • Kidney Stones
  • Metabolic Acidosis
  • Renal tubular acidosis
  • Uremia
  • Uric Acid Nephrolithiasis
  • Chronic metabolic acidosis

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
ATLANTIC BIOLOGICALS CORP.
17856-0677
ORAL
550 mg in 5 mL
9/26/2018
Zydus Lifesciences Limited
65841-536
ORAL
5 meq in 1 1
10/3/2023
REMEDYREPACK INC.
70518-3160
ORAL
10 meq in 1 1
3/13/2024
Bryant Ranch Prepack
71335-1706
ORAL
10 meq in 1 1
2/25/2022
Bryant Ranch Prepack
63629-8759
ORAL
10 meq in 1 1
6/1/2022
Upsher-Smith Laboratories, LLC
0245-0071
ORAL
10 meq in 1 1
8/11/2022
Strides Pharma Inc.
42543-408
ORAL
15 meq in 1 1
5/25/2023
Mission Pharmacal Company
0178-0615
ORAL
15 meq in 1 1
1/8/2024
Zydus Pharmaceuticals (USA) Inc.
68382-536
ORAL
5 meq in 1 1
10/3/2023
Bryant Ranch Prepack
72162-2122
ORAL
5 meq in 1 1
1/19/2022

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Potassium Citrate Granules
国药准字H20065593
化学药品
颗粒剂
7/23/2020
Potassium Citrate Granules
国药准字H20054682
化学药品
颗粒剂
5/22/2020
Potassium Citrate Granules
国药准字H20074119
化学药品
颗粒剂
4/12/2022
Potassium Citrate Granules
国药准字H10970220
化学药品
颗粒剂
3/12/2020
Potassium Citrate Granules
国药准字H22024249
化学药品
颗粒剂
4/8/2020

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath